1 – 10 of 27
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk
(
- Contribution to journal › Article
- 2022
-
Mark
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers
(
- Contribution to journal › Article
-
Mark
Breast cancer risks associated with missense variants in breast cancer susceptibility genes
(
- Contribution to journal › Article
- 2021
-
Mark
The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant
(
- Contribution to journal › Article
- 2019
-
Mark
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer
(
- Contribution to journal › Article
- 2017
-
Mark
Oral contraceptive use and breast cancer risk: A cohort study of BRCA1 and BRCA2 mutation carriers
2017) American Association for Cancer Research (AACR) 108th Annual Meeting 2017 In Cancer Research 77(13 Suppl 1).(
- Contribution to journal › Published meeting abstract
- 2016
-
Mark
Risk of male breast cancer in users of testosterone 5a reductase inhibitors
2016) 2016 Annual Meeting of the American Society of Clinical Oncology In Journal of Clinical Oncology 34(Suppl 15).(
- Contribution to journal › Published meeting abstract
- 2015
-
Mark
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
(
- Contribution to journal › Article
- 2012
-
Mark
Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers
(
- Contribution to journal › Article
-
Mark
Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers
(
- Contribution to journal › Article